Argitalpenak (23) Antonio Albaya Moreno argitalpenak

2024

  1. Applicability of an unsupervised cluster model developed on first wave COVID-19 patients in second/third wave critically ill patients

    Medicina Intensiva, Vol. 48, Núm. 6, pp. 326-340

  2. Association of obesity on the outcome of critically ill patients affected by COVID-19

    Medicina Intensiva, Vol. 48, Núm. 3, pp. 142-154

2023

  1. A differential therapeutic consideration for use of corticosteroids according to established COVID-19 clinical phenotypes in critically ill patients

    Medicina Intensiva, Vol. 47, Núm. 1, pp. 23-33

  2. Risk factors for developing ventilator-associated lower respiratory tract infection in patients with severe COVID-19: a multinational, multicentre study, prospective, observational study

    Scientific reports, Vol. 13, Núm. 1, pp. 6553

2022

  1. Dexamethasone as risk-factor for ICU-acquired respiratory tract infections in severe COVID-19

    Journal of Critical Care, Vol. 69

  2. Negative predictive value of procalcitonin to rule out bacterial respiratory co-infection in critical covid-19 patients

    Journal of Infection, Vol. 85, Núm. 4, pp. 374-381

2021

  1. Corticosteroid treatment and mortality in mechanically ventilated COVID-19-associated acute respiratory distress syndrome (ARDS) patients: a multicentre cohort study

    Annals of Intensive Care, Vol. 11, Núm. 1

  2. Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in Spain

    Critical Care, Vol. 25, Núm. 1

  3. Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: A multicentre retrospective cohort study

    The Lancet Regional Health - Europe, Vol. 11

2019

  1. The association of cardiovascular failure with treatment for ventilator-associated lower respiratory tract infection

    Intensive Care Medicine, Vol. 45, Núm. 12, pp. 1753-1762

2018

  1. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study

    Intensive Care Medicine, Vol. 44, Núm. 9, pp. 1470-1482

2016

  1. Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome

    Critical Care, Vol. 20, Núm. 1

2015

  1. Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): A multicentre, prospective, observational study

    The Lancet Respiratory Medicine, Vol. 3, Núm. 11, pp. 859-868

  2. World alliance against antibiotic resistance: The WAAAR declaration against antibiotic resistance

    Medicina Intensiva, Vol. 39, Núm. 1, pp. 34-39

2014

  1. Infections, antibiotic treatment and mortality in patients admitted to ICUs in countries considered to have high levels of antibiotic resistance compared to those with low levels

    BMC Infectious Diseases, Vol. 14, Núm. 1

2011

  1. Acute kidney injury in critical ill patients affected by influenza A (H1N1) virus infection

    Critical Care, Vol. 15, Núm. 1

  2. Community-acquired respiratory coinfection in critically III patients with pandemic 2009 influenza A(H1N1) virus

    Chest, Vol. 139, Núm. 3, pp. 555-562

  3. Impact of obesity in patients infected with 2009 influenza A(H1N1)

    Chest, Vol. 139, Núm. 2, pp. 382-386

  4. Severe pandemic (H1N1)v influenza A infection: Report on the first deaths in Spain

    Respirology, Vol. 16, Núm. 1, pp. 78-85

2010

  1. Pandemic Influenza A in the ICU: Experience in Spain and Latin America GETGAG/SEMICYUC/(Spanish Work Group on Severe Pandemic Influenza A/SEMICYUC)

    Medicina Intensiva, Vol. 34, Núm. 2, pp. 87-94